Rossari Biotech Ltd (ROSSARI) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003405,
    "name": "Rossari Biotech",
    "stock_name": "Rossari Biotech",
    "full_name": "Rossari Biotech Ltd",
    "name_url": "stocks-analysis/rossari-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "533.75",
    "chg": 1.2,
    "chgp": "0.23%",
    "dir": 1,
    "prev_price": "532.55",
    "mcapval": "3,013.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543213,
    "symbol": "ROSSARI",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE02A801020",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "79.59 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/rossari-biotech-1003405-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Rossari Biotech technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-rossari-biotech-technically-bullish-or-bearish-3743184",
        "imagepath": "",
        "date": "2025-12-03 08:56:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Current Price Action and Trend</strong></p>\n<p>As of 2 December 2025, Rossari Biotech’s technical trend shifted from bearish to mildly bearish, signalling a tentative improvement but still reflecting underlying weakness. The stock closed at ₹606.00, marginally higher than the previous close of ₹601.30, with intraday trading ranging between ₹595.50 and ₹606.00. This price action indicates some buying interest near the lower end of its 52-week range, which spans from ₹568.05 to ₹883.00.</p>\n<p>Despite this modest uptick, the stock remains significantly below its 52-week high, underscoring the challenges it faces in regaining momentum. The current price level is closer to the lower band of its annual range, suggesting that investors remain cautious amid broader market uncertainties ..."
      },
      {
        "title": "Rossari Biotech: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rossari-biotech-upgraded-to-hold-as-technicals-improve-amidst-flat-financials-3743155",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RossariBiotech_mojoScore_3743155.png",
        "date": "2025-12-03 08:25:49",
        "description": "Rossari Biotech, a key player in the Specialty Chemicals sector, has experienced a revision in its market assessment following a detailed review of its financial performance, valuation metrics, technical indicators, and overall quality parameters. This article explores the factors influencing the recent changes in the company’s evaluation, providing investors with a comprehensive understanding of its current standing."
      },
      {
        "title": "Rossari Biotech Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-technical-momentum-shifts-amid-mixed-market-signals-3743000",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RossariBiotech_technicaldot_3743000.png",
        "date": "2025-12-03 08:08:46",
        "description": "Rossari Biotech, a key player in the specialty chemicals sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent data reveals a transition from a bearish technical trend to a mildly bearish stance, underscoring a period of consolidation and cautious investor sentiment."
      },
      {
        "title": "How has been the historical performance of Rossari Biotech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-rossari-biotech-3742272",
        "imagepath": "",
        "date": "2025-12-02 23:04:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Rossari Biotech's net sales have shown a remarkable upward trend, rising from ₹600.09 crores in March 2020 to ₹2,080.29 crores by March 2025. This more than threefold increase over five years underscores the company's expanding market presence and product demand. Correspondingly, the total operating income mirrored this growth, reflecting the absence of other operating income during this period.</p>\n<p>Profitability metrics have also improved significantly. The consolidated net profit increased from ₹65.25 crores in March 2020 to ₹136.38 crores in March 2025, nearly doubling in size. Earnings per share (EPS) followed suit, climbing from ₹12.86 to ₹24.64, indicating enhanced returns for shareholders. Despite this growth, the profit after tax (PAT) mar..."
      },
      {
        "title": "Why is Rossari Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-rossari-biotech-fallingrising-3729992",
        "imagepath": "",
        "date": "2025-11-26 01:24:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Rossari Biotech’s share price has been on a consistent decline, losing 5.73% over the past six trading days. The stock is currently trading close to its 52-week low, just 4.43% above the lowest price of ₹568.05 recorded during this period. This proximity to the annual low signals sustained selling pressure and investor caution. Furthermore, the stock has underperformed its sector by 0.79% on the day, indicating relative weakness within its industry group.</p>\n<p>Technical indicators reinforce this bearish sentiment, with the share price trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Such positioning typically suggests a lack of short- and long-term momentum, discouraging fresh..."
      },
      {
        "title": "Rossari Biotech Sees Adjustment in Evaluation Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rossari-biotech-downgraded-to-sell-by-marketsmojo-amid-technical-and-financial-concerns-3714496",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RossariBiotech_mojoScore_3714496.png",
        "date": "2025-11-19 08:24:17",
        "description": "Rossari Biotech, a key player in the Specialty Chemicals sector, has undergone a revision in its evaluation reflecting changes across technical indicators, financial trends, valuation metrics, and quality parameters. This adjustment follows a period marked by subdued financial performance and evolving market dynamics, prompting a reassessment of the stock’s standing within its industry and broader market context."
      },
      {
        "title": "Is Rossari Biotech technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-rossari-biotech-technically-bullish-or-bearish-3713984",
        "imagepath": "",
        "date": "2025-11-19 08:17:18",
        "description": "As of 18 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for Rossari Biotech is bearish, with a moderate strength indicated by several key factors. The MACD on a monthly basis is bearish, while the weekly MACD shows mildly bullish signals, creating a divergence. The RSI on the monthly chart is bullish, but the weekly RSI shows no signal, indicating uncertainty. Moving averages on the daily chart are bearish, reinforcing the negative outlook. Additionally, Bollinger Bands are bearish on both weekly and monthly time frames, and the KST shows a bearish trend on the monthly while being mildly bullish weekly. Overall, the bearish trend is supported by the recent price action, with the stock trading below its previous close and significantly underperforming against the Sensex across multiple time frames...."
      },
      {
        "title": "Rossari Biotech Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-technical-momentum-shifts-amid-bearish-signals-3714371",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RossariBiotech_technicaldot_3714371.png",
        "date": "2025-11-19 08:10:35",
        "description": "Rossari Biotech, a key player in the Specialty Chemicals sector, has experienced a notable shift in its technical parameters, reflecting a change in price momentum. Recent data indicates a transition from a mildly bearish to a bearish technical trend, with mixed signals from key indicators such as MACD, RSI, and moving averages. This evolving technical landscape warrants close attention from investors monitoring the stock’s performance against broader market benchmarks."
      },
      {
        "title": "How has been the historical performance of Rossari Biotech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-rossari-biotech-3713232",
        "imagepath": "",
        "date": "2025-11-18 23:02:00",
        "description": "Answer:\nThe historical performance of Rossari Biotech shows a consistent growth trajectory in net sales and profitability over the years.\n\nBreakdown:\nRossari Biotech's net sales have increased significantly from INR 600.09 crore in March 2020 to INR 2,080.29 crore in March 2025, reflecting a strong upward trend. The total operating income has followed a similar pattern, reaching INR 2,080.29 crore in March 2025, up from INR 600.09 crore in March 2020. The operating profit (PBDIT) has also improved, rising from INR 108.46 crore in March 2020 to INR 269.08 crore in March 2025, although the operating profit margin has slightly decreased from 17.45% in March 2020 to 12.74% in March 2025. Profit before tax has grown from INR 88.06 crore in March 2020 to INR 184.21 crore in March 2025, and profit after tax has increased from INR 65.47 crore to INR 135.40 crore over the same period. The company's total assets have..."
      }
    ],
    "total": 156,
    "sid": "1003405",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/rossari-biotech-1003405"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "02-Feb-2026",
      "details": "Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) 2015",
      "datetime": "29-Jan-2026",
      "details": "Receipt of award in relation to arbitration proceedings in connection with Unitop Chemicals Private Limited.",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) 2015",
      "datetime": "23-Jan-2026",
      "details": "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Rossari Biotech Ltd has declared <strong>25%</strong> dividend, ex-date: 16 Aug 24",
          "dt": "2024-08-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Rossari Biotech technically bullish or bearish?

2025-12-03 08:56:04

Overview of Current Price Action and Trend As of 2 December 2025, Rossari Biotech’s technical trend shifted from bearish to mildly bearish, signalling a tentative improvement but still reflecting underlying weakness. The stock closed at ₹606.00, marginally higher than the previous close of ₹601.30, with intraday trading ranging between ₹595.50 and ₹606.00. This price action indicates some buying interest near the lower end of its 52-week range, which spans from ₹568.05 to ₹883.00. Despite this modest uptick, the stock remains significantly below its 52-week high, underscoring the challenges it faces in regaining momentum. The current price level is closer to the lower band of its annual range, suggesting that investors remain cautious amid broader market uncertainties ...

Rossari Biotech: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals

2025-12-03 08:25:49

Rossari Biotech, a key player in the Specialty Chemicals sector, has experienced a revision in its market assessment following a detailed review of its financial performance, valuation metrics, technical indicators, and overall quality parameters. This article explores the factors influencing the recent changes in the company’s evaluation, providing investors with a comprehensive understanding of its current standing.

Rossari Biotech Technical Momentum Shifts Amid Mixed Market Signals

2025-12-03 08:08:46

Rossari Biotech, a key player in the specialty chemicals sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent data reveals a transition from a bearish technical trend to a mildly bearish stance, underscoring a period of consolidation and cautious investor sentiment.

How has been the historical performance of Rossari Biotech?

2025-12-02 23:04:54

Revenue and Profit Growth Rossari Biotech's net sales have shown a remarkable upward trend, rising from ₹600.09 crores in March 2020 to ₹2,080.29 crores by March 2025. This more than threefold increase over five years underscores the company's expanding market presence and product demand. Correspondingly, the total operating income mirrored this growth, reflecting the absence of other operating income during this period. Profitability metrics have also improved significantly. The consolidated net profit increased from ₹65.25 crores in March 2020 to ₹136.38 crores in March 2025, nearly doubling in size. Earnings per share (EPS) followed suit, climbing from ₹12.86 to ₹24.64, indicating enhanced returns for shareholders. Despite this growth, the profit after tax (PAT) mar...

Why is Rossari Biotech falling/rising?

2025-11-26 01:24:42

Recent Price Movement and Market Context Rossari Biotech’s share price has been on a consistent decline, losing 5.73% over the past six trading days. The stock is currently trading close to its 52-week low, just 4.43% above the lowest price of ₹568.05 recorded during this period. This proximity to the annual low signals sustained selling pressure and investor caution. Furthermore, the stock has underperformed its sector by 0.79% on the day, indicating relative weakness within its industry group. Technical indicators reinforce this bearish sentiment, with the share price trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Such positioning typically suggests a lack of short- and long-term momentum, discouraging fresh...

Rossari Biotech Sees Adjustment in Evaluation Amid Mixed Financial and Technical Signals

2025-11-19 08:24:17

Rossari Biotech, a key player in the Specialty Chemicals sector, has undergone a revision in its evaluation reflecting changes across technical indicators, financial trends, valuation metrics, and quality parameters. This adjustment follows a period marked by subdued financial performance and evolving market dynamics, prompting a reassessment of the stock’s standing within its industry and broader market context.

Is Rossari Biotech technically bullish or bearish?

2025-11-19 08:17:18

As of 18 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for Rossari Biotech is bearish, with a moderate strength indicated by several key factors. The MACD on a monthly basis is bearish, while the weekly MACD shows mildly bullish signals, creating a divergence. The RSI on the monthly chart is bullish, but the weekly RSI shows no signal, indicating uncertainty. Moving averages on the daily chart are bearish, reinforcing the negative outlook. Additionally, Bollinger Bands are bearish on both weekly and monthly time frames, and the KST shows a bearish trend on the monthly while being mildly bullish weekly. Overall, the bearish trend is supported by the recent price action, with the stock trading below its previous close and significantly underperforming against the Sensex across multiple time frames....

Rossari Biotech Technical Momentum Shifts Amid Bearish Signals

2025-11-19 08:10:35

Rossari Biotech, a key player in the Specialty Chemicals sector, has experienced a notable shift in its technical parameters, reflecting a change in price momentum. Recent data indicates a transition from a mildly bearish to a bearish technical trend, with mixed signals from key indicators such as MACD, RSI, and moving averages. This evolving technical landscape warrants close attention from investors monitoring the stock’s performance against broader market benchmarks.

How has been the historical performance of Rossari Biotech?

2025-11-18 23:02:00

Answer: The historical performance of Rossari Biotech shows a consistent growth trajectory in net sales and profitability over the years. Breakdown: Rossari Biotech's net sales have increased significantly from INR 600.09 crore in March 2020 to INR 2,080.29 crore in March 2025, reflecting a strong upward trend. The total operating income has followed a similar pattern, reaching INR 2,080.29 crore in March 2025, up from INR 600.09 crore in March 2020. The operating profit (PBDIT) has also improved, rising from INR 108.46 crore in March 2020 to INR 269.08 crore in March 2025, although the operating profit margin has slightly decreased from 17.45% in March 2020 to 12.74% in March 2025. Profit before tax has grown from INR 88.06 crore in March 2020 to INR 184.21 crore in March 2025, and profit after tax has increased from INR 65.47 crore to INR 135.40 crore over the same period. The company's total assets have...

View All News